Achieving Regulatory Alignment for Anti-Infective Clinical Trials
| Autor: | Marco Cavaleri, Junko Sato, Sumathi Nambiar |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty business.industry Public health 030106 microbiology Anti-Bacterial Agents Clinical trial 03 medical and health sciences 030104 developmental biology Infectious Diseases Antibiotic resistance Anti-Infective Agents medicine Anti infectives Multiple stakeholder business Intensive care medicine |
| Zdroj: | ACS Infectious Diseases. 6:1308-1310 |
| ISSN: | 2373-8227 |
| Popis: | The growing concern of antimicrobial resistance coupled with the dearth of new antibacterial agents in development is a major public health threat. Multiple stakeholder efforts are underway to address the various challenges facing this field; while some progress has been made, antibacterial drug development continues to be a challenging area. The economic issues encountered in this space are probably today the most cogent; however, there are many other aspects that continue to pose challenges to enterprises engaging in this area, from the difficulties in discovering and advancing new classes of products to scientific issues with clinical trial design and feasibility in conducting these trials. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|